Brief: Tonix Pharmaceuticals Holding May Sell Up To $150 Million In Common Stock
11/06/2025 22:26
June 11 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O: TONIX PHARMACEUTICALS HOLDING CORP - MAY SELL UP TO $150 MILLION IN COMMON STOCK - SEC FILING TONIX PHARMACEUTICALS HOLDING CORP - ENTERS $75 MILLION PURCHASE AGREEMENT WITH LINCOLN PARK - SEC FILING Source text: [ID:n0001999371-25-007625] Further company coverage: TNXP.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Says Dr. Reddy's Files ANDA With Paragraph IV Patent Certification For Generic Tonmya
Brief: Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement For Tonmya®
Tonix Pharmaceuticals Holding Corp. reports results for the quarter ended June 30 - Earnings Summary
Tonix Q2 revenue rises sharply on TONMYA launch
Tonix Pharmaceuticals Holding Corp. expected to post a loss of $2.70 a share - Earnings Preview